BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
EGFR
,
Angiogenesis
,
Hepatitis
,
Endothelial cell
,
Amniocentesis
,
Aspirin
,
rs6983267
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptors glucagon
Summary
General Info
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes.
Weight loss with glucagon-like peptide-1 receptor agonists in Bardet-Biedl syndrome.
What Is the Mechanism Driving the Reduction of Cardiovascular Events from Glucagon-like Peptide-1 Re…
Glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, and glucagon receptor poly-ag…
Glucagon Receptor Inhibition Reduces Hyperammonemia and Lethality in Male Mice with Urea Cycle Disor…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patien…
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy…
A Study in People With Obesity to Test the Effects of Different Doses of BI 456906 Compared With Sem…
A Dose-response Study Examining the Contribution of GLP-1 Receptor Signaling to Glucagon-stimulated …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ